|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
increases metabolic processing increases reduction affects abundance multiple interactions affects response to substance |
ISO EXP |
HSD11B1 protein results in increased metabolism of 11-dehydrocorticosterone HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone HSD11B1 gene mutant form affects the abundance of 11-dehydrocorticosterone [HSD11B1 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; [HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] which results in increased chemical synthesis of Corticosterone; Resveratrol inhibits the reaction [HSD11B1 protein results in increased metabolism of 11-dehydrocorticosterone]; Ziram inhibits the reaction [[HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] which results in increased chemical synthesis of Corticosterone]; Ziram inhibits the reaction [HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] HSD11B1 gene affects the susceptibility to 11-dehydrocorticosterone |
CTD |
PMID:16751407 PMID:23814014 PMID:25061560 PMID:26859423 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
EXP |
[HSD11B2 protein results in increased metabolism of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; [HSD11B2 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; Ziram inhibits the reaction [[HSD11B2 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone] |
CTD |
PMID:26859423 PMID:32243540 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
11-dehydrocorticosterone results in increased expression of IL6 mRNA 11-dehydrocorticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA] |
CTD |
PMID:30993381 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
multiple interactions increases expression |
EXP |
Carbenoxolone inhibits the reaction [11-dehydrocorticosterone results in increased expression of SGK1 mRNA]; Tetradecanoylphorbol Acetate promotes the reaction [11-dehydrocorticosterone results in increased expression of SGK1 mRNA] |
CTD |
PMID:16533503 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
adrenosterone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
ISO |
[Calcitriol co-treated with Cortisone] results in decreased expression of ADIPOQ mRNA |
CTD |
PMID:19918113 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
multiple interactions |
ISO |
[AKR1D1 protein co-treated with NADP] results in increased reduction of Cortisone |
CTD |
PMID:25500266 |
|
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
Cortisone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] |
CTD |
PMID:15755911 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
Cortisone results in increased expression of CCL2 mRNA |
CTD |
PMID:24135201 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
increases reduction |
ISO |
DHRS7 protein results in increased reduction of Cortisone |
CTD |
PMID:24246760 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression multiple interactions |
ISO |
Cortisone results in increased expression of FABP4 mRNA 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Cortisone results in increased expression of FABP4 mRNA] |
CTD |
PMID:21315688 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Glul |
glutamate-ammonia ligase |
increases activity |
EXP |
Cortisone results in increased activity of GLUL protein |
CTD |
PMID:30993381 |
|
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
multiple interactions increases expression increases reduction affects response to substance increases metabolic processing affects metabolic processing |
ISO EXP |
[Calcitriol co-treated with Cortisone] results in increased expression of HSD11B1 mRNA; [HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; [HSD11B1 protein results in increased oxidation of Hydrocortisone] which results in increased chemical synthesis of Cortisone; [HSD11B1 protein results in increased reduction of Cortisone] which results in increased chemical synthesis of Hydrocortisone; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]] Cortisone results in increased expression of HSD11B1 mRNA 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Cortisone results in increased expression of and results in increased activity of HSD11B1 protein]; Cortisone results in increased expression of and results in increased activity of HSD11B1 protein [HSD11B1 protein affects the susceptibility to Cortisone] which results in decreased activity of NFE2L2 protein; [HSD11B1 protein co-treated with Cortisone] results in decreased expression of NQO1 mRNA; Cortisone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA] HSD11B1 protein results in increased metabolism of Cortisone HSD11B1 protein affects the metabolism of Cortisone |
CTD |
PMID:16054388 PMID:16751407 PMID:19918113 PMID:21315688 PMID:22606287 PMID:24135201 PMID:26859423 PMID:30993381 More...
|
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
increases chemical synthesis multiple interactions |
ISO |
HSD11B2 protein results in increased chemical synthesis of Cortisone [HSD11B2 protein results in increased oxidation of Hydrocortisone] which results in increased chemical synthesis of Cortisone; Ziram inhibits the reaction [[HSD11B2 protein results in increased oxidation of Hydrocortisone] which results in increased chemical synthesis of Cortisone] |
CTD |
PMID:22796344 PMID:26859423 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression |
ISO |
perfluorooctane sulfonic acid inhibits the reaction [Cortisone results in decreased expression of IL1B] |
CTD |
PMID:27288094 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
decreases expression multiple interactions |
ISO |
Cortisone results in decreased expression of IL6 perfluorooctane sulfonic acid inhibits the reaction [Cortisone results in decreased expression of IL6] |
CTD |
PMID:27288094 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
Cortisone results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:24135201 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO |
Cortisone results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:24135201 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO EXP |
[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]] [HSD11B1 protein affects the susceptibility to Cortisone] which results in decreased activity of NFE2L2 protein |
CTD |
PMID:22606287 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression |
ISO |
Cortisone results in increased expression of NOS2 protein |
CTD |
PMID:24135201 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
[HSD11B1 protein co-treated with Cortisone] results in decreased expression of NQO1 mRNA |
CTD |
PMID:22606287 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
affects binding multiple interactions increases activity |
ISO |
Cortisone binds to NR3C1 protein [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]] Cortisone results in increased activity of NR3C1 protein |
CTD |
PMID:15705660 PMID:15780662 PMID:22606287 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
increases activity |
ISO |
Cortisone results in increased activity of NR3C2 protein |
CTD |
PMID:15780662 |
|
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions increases expression |
ISO |
2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Cortisone results in increased expression of PPARG mRNA] |
CTD |
PMID:21315688 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
increases expression |
ISO |
Cortisone results in increased expression of PPARGC1A mRNA |
CTD |
PMID:23056435 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases phosphorylation |
ISO |
Cortisone results in increased phosphorylation of RELA protein |
CTD |
PMID:24135201 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
increases expression multiple interactions |
EXP |
Cortisone results in increased expression of SGK1 mRNA Phenylephrine promotes the reaction [Cortisone results in increased expression of SGK1 mRNA]; Tetradecanoylphorbol Acetate promotes the reaction [Cortisone results in increased expression of SGK1 mRNA] |
CTD |
PMID:16533503 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Cortisone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
increases expression multiple interactions |
ISO |
Cortisone results in increased expression of SLC2A4 mRNA 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Cortisone results in increased expression of SLC2A4 mRNA] |
CTD |
PMID:21315688 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
ISO |
Cortisone results in increased expression of TNF mRNA |
CTD |
PMID:24135201 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
A2m |
alpha-2-macroglobulin |
decreases expression |
ISO |
Prednisone results in decreased expression of A2M protein |
CTD |
PMID:11304663 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions affects response to substance increases secretion |
ISO |
Elacridar inhibits the reaction [ABCB1 protein results in increased secretion of Prednisone]; valspodar inhibits the reaction [ABCB1 protein results in increased secretion of Prednisone] ABCB1A protein affects the susceptibility to Prednisone |
CTD |
PMID:15502009 PMID:22464980 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
affects response to substance |
ISO |
ABCB1B protein affects the susceptibility to Prednisone |
CTD |
PMID:15502009 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions increases activity |
ISO |
Prednisone promotes the reaction [ABCC3 protein affects the transport of calcein AM] Prednisone results in increased activity of ABCC3 protein |
CTD |
PMID:15979871 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
ISO |
[Prednisone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein |
CTD |
PMID:29782964 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases expression |
ISO |
Prednisone results in decreased expression of AKT1 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
decreases expression |
ISO |
Prednisone results in decreased expression of ALB mRNA |
CTD |
PMID:38439560 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Prednisone binds to and results in increased activity of AR protein mutant form |
CTD |
PMID:11956172 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression |
ISO |
Prednisone results in decreased expression of BAX mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Casp9 |
caspase 9 |
decreases expression |
ISO |
Prednisone results in decreased expression of CASP9 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
decreases expression |
ISO |
Prednisone results in decreased expression of CCL11 protein |
CTD |
PMID:15523430 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl12 |
C-C motif chemokine ligand 12 |
decreases expression |
ISO |
Prednisone results in decreased expression of CCL13 protein |
CTD |
PMID:15523430 |
|
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
|
|
G |
Cd2ap |
CD2-associated protein |
multiple interactions |
EXP |
Prednisone affects the reaction [Doxorubicin results in increased expression of CD2AP mRNA]; Prednisone inhibits the reaction [Doxorubicin results in increased expression of CD2AP protein] |
CTD |
PMID:16636307 |
|
NCBI chr 9:18,086,744...18,182,744
Ensembl chr 9:18,086,984...18,182,199
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
Prednisone results in increased expression of CDKN1A protein |
CTD |
PMID:15034294 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
Prednisone results in increased expression of CDKN1B protein |
CTD |
PMID:15034294 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
increases expression |
ISO |
Prednisone results in increased expression of CDKN2A protein |
CTD |
PMID:15034294 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
increases expression |
ISO |
Prednisone results in increased expression of CDKN2B protein |
CTD |
PMID:15034294 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
affects expression decreases expression |
ISO |
Prednisone affects the expression of CEBPA mRNA Prednisone results in decreased expression of CEBPA protein |
CTD |
PMID:38439560 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
decreases expression |
ISO |
Prednisone results in decreased expression of CPT1A mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
ISO |
Prednisone results in decreased expression of CXCL12 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
increases expression |
ISO |
Prednisone results in increased expression of CYP27A1 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
decreases expression |
ISO |
Prednisone results in decreased expression of DLK1 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions |
ISO |
[Prednisone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein |
CTD |
PMID:29782964 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Gcg |
glucagon |
multiple interactions decreases expression |
EXP |
[Fatty Acids, Unsaturated co-treated with Prednisone] results in increased expression of GCG mRNA Prednisone results in decreased expression of GCG mRNA |
CTD |
PMID:12524409 PMID:14705828 |
|
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
affects response to substance |
ISO |
GSTM1 gene polymorphism affects the susceptibility to Prednisone |
CTD |
PMID:15713801 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases activity |
ISO |
Prednisone results in increased activity of HIF1A protein |
CTD |
PMID:19502547 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
decreases expression |
ISO |
Prednisone results in decreased expression of HNF4A mRNA; Prednisone results in decreased expression of HNF4A protein |
CTD |
PMID:38439560 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[zafirlukast co-treated with Prednisone co-treated with Budesonide] inhibits the reaction [Antigens results in increased secretion of IFNG protein] |
CTD |
PMID:16160912 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
ISO |
Prednisone results in decreased expression of IGF1 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Il12a |
interleukin 12A |
multiple interactions |
ISO |
Prednisone results in increased expression of [IL12A protein binds to IL12B protein] |
CTD |
PMID:19584951 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
Prednisone results in increased expression of [IL12A protein binds to IL12B protein] |
CTD |
PMID:19584951 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il13 |
interleukin 13 |
decreases expression |
ISO |
Prednisone results in decreased expression of IL13 protein |
CTD |
PMID:15523430 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il4 |
interleukin 4 |
decreases expression |
ISO |
Prednisone results in decreased expression of IL4 protein |
CTD |
PMID:19584951 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
decreases expression |
ISO |
Prednisone results in decreased expression of IL5 protein |
CTD |
PMID:12722970 PMID:15523430 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
[Prednisone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein; [Prednisone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein |
CTD |
PMID:29782964 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Itgb1 |
integrin subunit beta 1 |
decreases expression |
ISO |
Prednisone results in decreased expression of ITGB1 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
EXP |
Prednisone results in decreased expression of JUN mRNA |
CTD |
PMID:12524409 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Krt19 |
keratin 19 |
increases expression |
ISO |
Prednisone results in increased expression of KRT19 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
decreases expression |
ISO |
Prednisone results in decreased expression of MAP2K1 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
decreases expression |
ISO |
Prednisone results in decreased expression of MAP2K2 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases expression |
ISO |
Prednisone results in decreased expression of MAPK1 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases expression |
ISO |
Prednisone results in decreased expression of MAPK3 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression |
ISO |
Prednisone results in decreased expression of MKI67 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Nphs2 |
NPHS2 stomatin family member, podocin |
multiple interactions |
EXP |
Prednisone inhibits the reaction [Doxorubicin results in increased expression of NPHS2 mRNA] |
CTD |
PMID:16636307 |
|
NCBI chr13:68,448,720...68,461,312
Ensembl chr13:68,448,926...68,461,313
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
ISO |
Prednisone binds to and results in increased activity of NR3C1 protein |
CTD |
PMID:28973534 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
increases expression |
ISO |
Prednisone results in increased expression of PCK1 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
Prednisone results in decreased expression of PCNA mRNA; Prednisone results in decreased expression of PCNA protein |
CTD |
PMID:38439560 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Plat |
plasminogen activator, tissue type |
increases expression |
ISO |
Prednisone results in increased expression of PLAT protein |
CTD |
PMID:10452346 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Pomc |
proopiomelanocortin |
decreases expression |
ISO |
Prednisone results in decreased expression of POMC protein modified form |
CTD |
PMID:1977371 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
decreases expression |
ISO |
Prednisone results in decreased expression of PPARA mRNA |
CTD |
PMID:38439560 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Prom1 |
prominin 1 |
decreases expression |
ISO |
Prednisone results in decreased expression of PROM mRNA |
CTD |
PMID:38439560 |
|
NCBI chr14:66,989,545...67,094,534
Ensembl chr14:66,990,160...67,094,527
|
|
G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
decreases expression |
ISO |
Prednisone results in decreased expression of PTPRC mRNA |
CTD |
PMID:38439560 |
|
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
|
|
G |
Pygm |
glycogen phosphorylase, muscle associated |
decreases expression |
ISO |
Prednisone results in decreased expression of PYGM protein |
CTD |
PMID:8815173 |
|
NCBI chr 1:203,690,550...203,705,369
Ensembl chr 1:203,690,533...203,705,368
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
Prednisone results in decreased phosphorylation of and results in decreased activity of RB1 protein |
CTD |
PMID:15034294 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Serpinc1 |
serpin family C member 1 |
increases expression |
ISO |
Prednisone results in increased expression of SERPINC1 protein |
CTD |
PMID:11304663 |
|
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Prednisone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
affects expression |
ISO |
Prednisone affects the expression of SOX9 mRNA |
CTD |
PMID:38439560 |
|
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
|
|
G |
Spmip11 |
sperm microtubule inner protein 11 |
multiple interactions |
EXP |
Prednisone inhibits the reaction [Doxorubicin results in decreased phosphorylation of NPHS1 protein]; Prednisone inhibits the reaction [Doxorubicin results in increased expression of NPHS1 protein] |
CTD |
PMID:16636307 PMID:19293598 |
|
NCBI chr 7:129,720,950...129,742,485
Ensembl chr 7:129,720,950...129,742,485
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
ISO |
Prednisone results in decreased expression of TGFB1 protein |
CTD |
PMID:12722970 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
ISO |
Prednisone results in increased expression of TNF protein |
CTD |
PMID:19584951 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tyms |
thymidylate synthetase |
affects response to substance |
ISO |
TYMS gene polymorphism affects the susceptibility to Prednisone |
CTD |
PMID:15713801 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Vdr |
vitamin D receptor |
increases expression affects response to substance |
ISO |
Prednisone results in increased expression of VDR protein VDR gene polymorphism affects the susceptibility to Prednisone |
CTD |
PMID:7662588 PMID:15713801 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
Prednisone affects the reaction [Doxorubicin results in decreased expression of VEGFA protein] |
CTD |
PMID:19293598 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Glra1 |
glycine receptor, alpha 1 |
multiple interactions |
ISO |
RU 5135 binds to and results in decreased activity of GLRA1 protein |
CTD |
PMID:15081878 |
|
NCBI chr10:39,625,853...39,727,897
Ensembl chr10:39,629,459...39,727,162
|
|